The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...
MiMedx Group (NASDAQ:MDXG) said that it was pulling the plug on its knee osteoarthritis and regenerative medicine programs in order to focus on accelerating growth for its wound and surgical business.
DUBLIN--(BUSINESS WIRE)--The Regenerative Medicines: Bone and Joint Applications report has been added to ResearchAndMarkets.com's offering. The global market for regenerative medicine for bone and ...
The Phase 3 study is a global trial to evaluate improvements in both pain and function for up to 12 months following a MOTYS injection.
The future of healthcare is promising, with growth and innovation led by advancements in regenerative medicine. Companies like Regenity Biosciences are pioneering advancements in regenerative science ...
CellSeed Inc. (($JP:7776)) announced an update on their ongoing clinical study. Study Overview: CellSeed Inc. is conducting a Phase III clinical ...
KELO Sioux Falls on MSN
The glue that holds us together
Whatever your age, race, or gender, injuries are a part of life, especially among athletes. But a research team at South ...
Pine Brook-based boutique health care law firm Frier Levitt is launching a Regenerative Medicine, Anti-Aging and Wellness multidisciplinary practice group. Partner Arielle Miliambro – a 2025 NJBIZ ...
"Orthobiologics is a field of regenerative medicine that uses substances from your own body to promote healing, and PRP (platelet-rich plasma) is the most common orthobiologic treatment."He was ...
Prominently featured in The Inner Circle, Deryk G. Jones, MD, FAAOS, FAOA is acknowledged as a Pinnacle Lifetime Member for his contributions to Advancing Orthopedic Surgery and Regenerative Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback